Literature DB >> 17455801

Retrospective sequence analysis of the human PRNP gene from the formaldehyde-fixed paraffin-embedded tissues: report of two cases of Creutzfeldt-Jakob disease.

J Sikora1, A Srbová, F Koukolík, R Matej.   

Abstract

The definitive diagnosis of the CJD (Creutzfeldt-Jakob disease; very rare neurodegenerative disorder) can be established only on the basis of post-mortem examination of the central nervous system tissue. Formaldehyde-fixed paraffin-embedded (FFPE) tissue samples may thus constitute the only material available for molecular pathology analyses. We performed post-mortem analysis of the coding region of the prion-protein gene (PRNP)-sequence variations in two definite CJD cases suggestive of genetic form. Only FFPE tissues were available for molecular analyses. The PRNP gene open reading frame was amplified from the genomic DNA (FFPE isolated) in four overlapping, two round semi-nested PCR products that were directly sequenced. We found known pathogenic sequence variation g.532 G>A (Asp178Asn) in patient 1 but we did not find any pathogenic sequence variation in patient 2 despite her origin from the Slovak Orava region. Based on these results, we were able to discriminate between genetic and sporadic form of CJD in patient 1 and 2, respectively. The established method was found to be efficient for the sequence-variation analysis of the entire PRNP gene coding region using the genomic DNA isolated from the FFPE tissues; it can be employed in other retrospective molecular studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17455801     DOI: 10.1007/bf02931629

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  27 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

Review 2.  Effect of fixatives and tissue processing on the content and integrity of nucleic acids.

Authors:  Mythily Srinivasan; Daniel Sedmak; Scott Jewell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction.

Authors:  D P Jackson; F A Lewis; G R Taylor; A W Boylston; P Quirke
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

Review 4.  DNA polymerase fidelity and the polymerase chain reaction.

Authors:  K A Eckert; T A Kunkel
Journal:  PCR Methods Appl       Date:  1991-08

5.  Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation.

Authors:  C Wong; R A DiCioccio; H J Allen; B A Werness; M S Piver
Journal:  Cancer Genet Cytogenet       Date:  1998-11

6.  Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.

Authors:  H S Lee; N Sambuughin; L Cervenakova; J Chapman; M Pocchiari; S Litvak; H Y Qi; H Budka; T del Ser; H Furukawa; P Brown; D C Gajdusek; J C Long; A D Korczyn; L G Goldfarb
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

7.  The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion.

Authors:  W M Barnes
Journal:  Gene       Date:  1992-03-01       Impact factor: 3.688

8.  Genomic structure of the human prion protein gene.

Authors:  C Puckett; P Concannon; C Casey; L Hood
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

9.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

10.  In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR.

Authors:  Nancy Quach; Myron F Goodman; Darryl Shibata
Journal:  BMC Clin Pathol       Date:  2004-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.